Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 100,000 shares at $68.33 ($6.7M) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Open-market sale of $6.7M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.82 | 11,050 | $738K | 11.0% |
| 2 | $66.82 | 11,050 | $738K | 11.0% |
| 3 | $67.35 | 33,938 | $2.3M | 33.9% |
| 4 | $67.35 | 33,938 | $2.3M | 33.9% |
| 5 | $68.33 | 5,012 | $342K | 5.1% |
| 6 | $68.33 | 5,012 |
| $342K |
| 5.1% |
| Total | $67.33 avg | 100,000 | $6.7M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |